MAPT and Alzheimer disease: Moreover, although they induced GRIN3A knockout to modulate pathogenesis of AD, they did not confirm the direct evidence that amyloid beta plaques or tau, major pathological hallmarks of AD, can affect NR3A levels and its postsynaptic activity.